AUM Pharmacy
Health Hub
Search Icon

AUM Pharmacy

Hi there!

Hello, Login
All Categories
VisaVisaVisa
slide-0
slide-1
slide-2
slide-3
slide-4
slide-5

Glimisave M 0.5 Tablet PR

Prescription Icon
Prescription Required

Marketer

Eris Lifesciences Ltd

Salt Composition

Glimepiride (0.5mg) + Metformin (500mg)

Overview Glimisave M 0.5 Tablet PR

Metformin and Glimepiride combination tablets (0.5mg) are classified as antidiabetic agents, specifically designed for managing type 2 diabetes in adults. This dual-action medication helps regulate blood glucose. Administer this medication with food, consistently at the same time daily for optimal efficacy. Dosage will be determined and adjusted by your physician based on your blood sugar response. Continuous use is crucial, even if feeling well or experiencing controlled blood sugar, as abrupt cessation can lead to elevated glucose levels, increasing the risk of complications such as nephropathy, retinopathy, neuropathy, and limb loss. Remember, this medication is only one component of a comprehensive diabetes management plan, incorporating a balanced diet, regular physical activity, and weight management as directed by your doctor. Lifestyle modifications are integral to successful diabetes control. Hypoglycemia (low blood sugar) is a common side effect, characterized by symptoms like sweating, lightheadedness, cephalgia, and tremors. Learn to recognize these symptoms and treat them promptly with readily available glucose sources, such as sweets or fruit juice. Alcohol consumption elevates hypoglycemia risk and should be limited. Additional potential side effects include altered taste perception, nausea, diarrhea, abdominal discomfort, headache, and upper respiratory infections. Weight gain may also occur. This medication is contraindicated in patients with type 1 diabetes, diabetic ketoacidosis, or severe hepatic or renal impairment. Individuals with a history of cardiovascular disease should inform their physician before commencing treatment. Pregnant or lactating women should seek medical advice prior to use. Regular blood glucose monitoring is essential, and your doctor may order blood tests to track blood cell counts and liver function.

Primary Ingredients of Glimisave M 0.5 Tablet PR

No text provided to rephrase.

Uses of Glimisave M 0.5 Tablet PR

Managing type 2 diabetes

Major Benefits of Glimisave M 0.5 Tablet PR:

Follow your doctor's instructions or consult the product label for guidance prior to administration. Take Glimisave M 0.5 Tablet PR with food.

Common Side effects of Glimisave M 0.5 Tablet PR:

  • Headache
  • Hypoglycemia (low blood glucose level)
  • Nausea
  • Diarrhea

How to use Glimisave M 0.5 Tablet PR:

Follow your doctor's instructions or consult the product label for usage guidelines. Take Glimisave M 0.5 Tablet PR with food.

How Glimisave M 0.5 Tablet PR works:

Glimisave M 0.5 PR tablets contain glimepiride and metformin, two medications used to manage diabetes. Glimepiride, a sulfonylurea, stimulates the pancreas to release more insulin, thus reducing blood sugar. Metformin, a biguanide, acts by decreasing liver glucose output, slowing intestinal glucose absorption, and enhancing insulin responsiveness.

SAFETY ADVICE

AlcoholAlcoholUNSAFE

Combining Glimisave M 0.5 Tablet PR and alcohol poses a safety risk.

PregnancyPregnancyCONSULT YOUR DOCTOR

The use of Glimisave M 0.5 Tablet PR during pregnancy may pose risks. While human data is scarce, animal research indicates potential harm to the unborn child. A physician will assess the advantages against possible dangers prior to prescribing. Seek medical advice.

Breast feedingBreast feedingUNSAFE

Using Glimisave M 0.5 Tablet PR while breastfeeding is contraindicated due to potential infant toxicity. Evidence indicates a risk of harm to the nursing infant.

DrivingDrivingCAUTION

Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these blood sugar imbalances.

KidneyKidneyCAUTION

Exercise caution when administering Glimisave M 0.5 Tablet PR to individuals with impaired renal function; dosage modification may be necessary. Consult your physician for guidance. Glimisave M 0.5 Tablet PR is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of renal function is recommended during treatment.

LiverLiverCAUTION

Patients with liver impairment should use Glimisave M 0.5 Tablet PR cautiously, potentially requiring dosage modification. A physician's consultation is advised. For those with mild to moderate liver disease, initiation should be at a low dose; however, it's contraindicated in patients with severe hepatic dysfunction.

What if you forget to take Glimisave M 0.5 Tablet PR :

Should you forget to take your Glimisave M 0.5 Tablet PR, administer it immediately upon remembering. However, if your next scheduled dose is imminent, omit the missed dose and resume your usual medication regimen. Never take a double dose.

Facts to Know About Glimisave M 0.5 Tablet PR

LabelValue
Developing Habits No.
Type of Treatment Diabetes Management

FAQs on Glimisave M 0.5 Tablet PR

Store this medication in its original, tightly closed container as directed on the label. Discard any unused medication and keep it out of reach of children, pets, and others.
Glimisave M 0.5 Tablet PR can cause lactic acidosis, a serious medical emergency characterized by excessive blood lactic acid (also known as MALA, or Metformin-associated lactic acidosis). This rare but potentially harmful side effect is more likely in patients with kidney disease, the elderly, or those who consume large amounts of alcohol. Symptoms include muscle pain or weakness, dizziness, fatigue, cold extremities, shortness of breath, nausea, vomiting, abdominal pain, and slow heart rate. If you experience these, stop taking Glimisave M 0.5 Tablet PR and seek immediate medical attention.
Glimisave M 0.5 Tablet PR combines glimepiride and metformin to manage type 2 diabetes mellitus (DM) in adults. It enhances blood glucose control when used with diet and exercise. Glimepiride stimulates insulin release from the pancreas, while metformin reduces liver glucose production and improves insulin sensitivity. This combination is unsuitable for type 1 DM.
Glimisave M 0.5 Tablet PR may cause common side effects such as hypoglycemia, altered taste, nausea, stomach pain, diarrhea, and headache. Rare but serious side effects include lactic acidosis. Prolonged use can also result in vitamin B12 deficiency.
Prolonged Glimisave M 0.5 Tablet PR use can lead to vitamin B12 deficiency by impairing its absorption. This deficiency, if left untreated, may cause anemia, nerve damage (manifesting as tingling, numbness in extremities, weakness, and gait instability), urinary issues, and cognitive changes. To mitigate this risk, annual supplemental vitamin B12 is recommended by some researchers.
Glimisave M 0.5 Tablet PR can cause low blood sugar (hypoglycemia), manifesting as nausea, headache, irritability, hunger, sweating, dizziness, rapid heart rate, anxiety, or shakiness. This risk increases with missed meals, alcohol consumption, excessive exercise, or concurrent use of other antidiabetic medications. Regular blood sugar monitoring is crucial. Carry a fast-acting sugar source, such as glucose tablets, honey, or fruit juice, at all times.
Combining Glimisave M 0.5 Tablet PR with alcohol is unsafe. This combination can dangerously lower blood sugar (hypoglycemia) and raise the risk of lactic acidosis.
Glimisave M 0.5 Tablet PR
90
MRP 104
13% off